|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2002-7-19
|
|
pubmed:abstractText |
The widespread use of protease inhibitors (PI) has been associated with abnormalities in the lipid profile of HIV-1-infected patients. Treatment simplification approaches in which PI are replaced by nevirapine (NVP) have been shown to improve PI-related toxicity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
5
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1383-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12131215-Adult,
pubmed-meshheading:12131215-Anti-HIV Agents,
pubmed-meshheading:12131215-Cholesterol,
pubmed-meshheading:12131215-Cholesterol, HDL,
pubmed-meshheading:12131215-Cholesterol, LDL,
pubmed-meshheading:12131215-Female,
pubmed-meshheading:12131215-HIV Infections,
pubmed-meshheading:12131215-HIV-1,
pubmed-meshheading:12131215-Humans,
pubmed-meshheading:12131215-Lipodystrophy,
pubmed-meshheading:12131215-Lipoproteins,
pubmed-meshheading:12131215-Magnetic Resonance Spectroscopy,
pubmed-meshheading:12131215-Male,
pubmed-meshheading:12131215-Nevirapine,
pubmed-meshheading:12131215-Prospective Studies,
pubmed-meshheading:12131215-Protease Inhibitors
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.
|
|
pubmed:affiliation |
Lluita contra la SIDA Foundation, Germans Trias i Pujol University Hospital, Universitat Autónoma de Barcelona, Badalona, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
